Ligand‐independent <scp>EphA2</scp> contributes to chemoresistance in small‐cell lung cancer by enhancing <scp>PRMT1</scp>‐mediated <scp>SOX2</scp> methylationShumei Liang(Shandong Provincial Hospital), Linlang Guo(Zhujiang Hospital)Cancer ScienceNovember 15, 202210.1111/cas.15653Cited by 27SaveCiteExport RISWatch citationsRelated PapersMETTL3 serves an oncogenic role in human ovarian cancer cells partially via the AKT signaling pathway|Oncology Letters|2020|54WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway|British Journal of Cancer|2016|38